Back to the drug test guide

Propoxyphene Test Evidence

Has Caused a False Positive

Ranitidine

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • Adding ranitidine to urine at 800 micrograms/mL made the dedicated propoxyphene strip positive.

Keep in Mind

  • This incidental high-concentration finding is specific to one point-of-care cup.

Test Studied

  • Alere Integrated E-Z Split Key Cup II, propoxyphene strip

Depends on the Brand of Test

Diphenhydramine

Source Schneider and Wennig, J Anal Toxicol 1999

What It Found

  • A laboratory letter reported EMIT II interference.

Test Studied

  • Historical EMIT II

2 sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • A 2009 compilation listed weak Biosite Triage reactivity at 70 micrograms/mL but no reaction on several other evaluated reagents, including the Syva reagent in its comparison.

Tests Studied

  • Biosite Triage PPX
  • Comparisons with other propoxyphene reagents

Source Poklis et al., J Anal Toxicol 2004

What It Found

  • Diphenhydramine cross-reacted in urine during specificity testing of Triage PPY.

Keep in Mind

  • This experiment does not establish a positive at a usual dose or on other propoxyphene assays.

Test Studied

  • BIOSITE TRIAGE Plus Propoxyphene (TPP), 300 ng/mL target cutoff

All 4 sources Schneider and Wennig, J Anal Toxicol 1999 Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Poklis et al., J Anal Toxicol 2004

Keep in Mind

  • Separate primary-report and package-insert findings differ.
  • Device, generation, concentration and metabolites may matter.
  • A personal risk at ordinary doses is unknown.

Clemastine

Both sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The compiled manufacturer data list Clemastine as weakly reactive at 40 micrograms/mL.
  • The same compilation lists no reaction for Roche Cobas c.

Keep in Mind

  • These figures came from historical reagent information compiled in 2009.
  • They do not establish risk after usual doses.

Test Studied

  • Biosite Triage PPX, historical 300 ng/mL cutoff

Cyclobenzaprine

Both sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 manufacturer-data review lists weak reactivity at 99 micrograms/mL on Abbott and 80 on Syva.
  • Biosite Triage did not react under the reported conditions.

Keep in Mind

  • Package-insert data describe those reagent versions and challenge concentrations.
  • Patient event rates were not determined.

Test Studied

  • Historical Abbott Architect and Syva EMIT propoxyphene reagents, 300 ng/mL cutoff

Imipramine

Both sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 manufacturer-data review lists weak reactivity at 40 micrograms/mL on Abbott and 30 on Syva.
  • Beckman, Biosite Triage, Microgenics DRI and Roche Cobas c did not react under the reported conditions.

Keep in Mind

  • Package-insert data describe those reagent versions and challenge concentrations.
  • Patient event rates were not determined.

Test Studied

  • Historical Abbott Architect and Syva EMIT propoxyphene reagents, 300 ng/mL cutoff

Methaqualone

Both sources Krasowski et al., BMC Emerg Med 2009 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The compiled manufacturer data list Methaqualone as weakly reactive at 100 micrograms/mL.
  • Abbott Architect, Beckman, Microgenics DRI, Roche and Syva were listed as unreactive.

Keep in Mind

  • These figures came from historical reagent information compiled in 2009.
  • They do not establish risk after usual doses.

Test Studied

  • Biosite Triage PPX, historical 300 ng/mL cutoff

The Test Is Made to Find It

Propoxyphene

Source Kintz and Mangin, J Anal Toxicol 1993

What It Found

  • This test detected propoxyphene, and measured its genuine major metabolite norpropoxyphene with 29.3–92.6% cross-reactivity depending on concentration.

Keep in Mind

  • Validation included urine and other biological specimens.
  • The metabolite percentages characterize the assay, not detection rates in patients.

Test Studied

  • Abbott TDx propoxyphene FPIA and GC-MS